title: Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
authors.forename: V K
authors.initials: VK
authors.lastname: Sharma
authors.forename: G
authors.initials: G
authors.lastname: Tsivgoulis
authors.forename: J H
authors.initials: JH
authors.lastname: Tan
authors.forename: B K C
authors.initials: BK
authors.lastname: Ong
authors.forename: B P L
authors.initials: BP
authors.lastname: Chan
authors.forename: H L
authors.initials: HL
authors.lastname: Teoh
mesh_terms: D000328:Adult; D000368:Aged; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012846:Singapore; D020521:Stroke / Q000188:drug therapy* / Q000208:ethnology; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator